Taking a look at the company’s numbers in an 8-K filing, we can see net revenues increased 15.5% to $44.6 billion, which is a year-over-year number. Operating profits increased 20.9% to $2.8 billion, which again, this is a year-over-year number. Year-to-date cash flow from operations is $7.9 billion and generated free cash flow of $6.6 billion. CVS does have a note for the 2017 fiscal year that their projections included a projected loss of more than 40 million retail prescriptions related to new restricted pharmacy networks.
Looking at the chart, it appears price seems to be falling a bit, as it is beginning to make lower highs and lower lows. Just like most stocks, the price has increase steadily for years and is now maybe being over extended. I would be watching for a healthy retrace and begin looking for a solid entry point if this is a stock you want to invest in. Right now, it appears a top has been made and now patience is key.
Valuation Drivers Correlation
|Investment Horizon||30 Days Login to change|